Javascript must be enabled to continue!
Insulin Modulates Hippo Signaling by Impairing YAP Function
View through CrossRef
Yes‐associated protein (YAP) is the main transcriptional coactivator of the Hippo pathway, which regulates organ size, tissue homeostasis, and regeneration. YAP integrates multiple inputs from different signaling cascades. Recent evidence implicates YAP also in the control of nutrient and energy status of the cell, but the mechanisms underlying this function are unclear. In this study, we show that insulin modulates YAP activity in classic insulin target cells. We found by subcellular fractionation and Western blotting that insulin increases YAP phosphorylation, with a significant decrease in the abundance of YAP in the nuclei of HepG2 liver cells. Further, this regulation is likely mediated through the insulin receptor (IR), as overexpression of IR increased YAP phosphorylation. Proximity ligation assay analysis revealed a marked reduction in the interaction of YAP with TEA domain (TEAD) transcription factors in the nuclei of insulin‐treated cells. Consistent with these findings, insulin significantly impaired YAP/TEAD‐mediated transcription as measured by a dual luciferase assay in both HepG2 and C2C12 muscle cells. Further, quantitative PCR of HepG2 cells treated with insulin revealed reduced transcription of YAP regulated genes. Insulin alters transcription of numerous genes relevant to energy homeostasis, and we observed that knockdown of YAP by siRNA alters expression of genes in gluconeogenesis. Insulin stimulates activation of the phosphoinositide 3‐kinase (PI3K) pathway. The inhibitory effect of insulin on YAP transcription was abrogated by small‐molecule inhibitors of PI3K. Collectively, our results identify insulin as a previously undescribed suppressor of YAP activity and provide insight into an important link between the insulin and Hippo pathways.
Support or Funding Information
This work was supported by the National Institutes of Health Intramural Research Program.
This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in
The FASEB Journal
.
Title: Insulin Modulates Hippo Signaling by Impairing YAP Function
Description:
Yes‐associated protein (YAP) is the main transcriptional coactivator of the Hippo pathway, which regulates organ size, tissue homeostasis, and regeneration.
YAP integrates multiple inputs from different signaling cascades.
Recent evidence implicates YAP also in the control of nutrient and energy status of the cell, but the mechanisms underlying this function are unclear.
In this study, we show that insulin modulates YAP activity in classic insulin target cells.
We found by subcellular fractionation and Western blotting that insulin increases YAP phosphorylation, with a significant decrease in the abundance of YAP in the nuclei of HepG2 liver cells.
Further, this regulation is likely mediated through the insulin receptor (IR), as overexpression of IR increased YAP phosphorylation.
Proximity ligation assay analysis revealed a marked reduction in the interaction of YAP with TEA domain (TEAD) transcription factors in the nuclei of insulin‐treated cells.
Consistent with these findings, insulin significantly impaired YAP/TEAD‐mediated transcription as measured by a dual luciferase assay in both HepG2 and C2C12 muscle cells.
Further, quantitative PCR of HepG2 cells treated with insulin revealed reduced transcription of YAP regulated genes.
Insulin alters transcription of numerous genes relevant to energy homeostasis, and we observed that knockdown of YAP by siRNA alters expression of genes in gluconeogenesis.
Insulin stimulates activation of the phosphoinositide 3‐kinase (PI3K) pathway.
The inhibitory effect of insulin on YAP transcription was abrogated by small‐molecule inhibitors of PI3K.
Collectively, our results identify insulin as a previously undescribed suppressor of YAP activity and provide insight into an important link between the insulin and Hippo pathways.
Support or Funding Information
This work was supported by the National Institutes of Health Intramural Research Program.
This abstract is from the Experimental Biology 2018 Meeting.
There is no full text article associated with this abstract published in
The FASEB Journal
.
Related Results
Abstract 1671: Discovery of ETS-003, a potent and selective YAP/TAZ-TEAD PPI inhibitor with broad anti-tumor activity in Hippo-YAP aberrant cancers
Abstract 1671: Discovery of ETS-003, a potent and selective YAP/TAZ-TEAD PPI inhibitor with broad anti-tumor activity in Hippo-YAP aberrant cancers
Abstract
Hippo/YAP is a conserved signaling pathway controlling organ development, tissue regeneration and immune modulation. Cascade of tumor suppressor genes (N...
Data from Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis
Data from Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis
<div>Abstract<p>Dysregulation of Hippo signaling, especially the downstream effector YAP, is a critical driver of hepatocellular carcinoma (HCC). Therefore, identifying...
On Hippo of (Possibly) Rhegium
On Hippo of (Possibly) Rhegium
The Presocratic philosopher and medical writer Hippo is best known for two allusions, both markedly negative, in Aristotle (De Anima 405b1-5, Metaphysics 984a3-5). In the Metaphysi...
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
Insulin is one of the most important hormones that controls the glucose level in blood. Therefore, the investigation of insulin is very important for the diabetic research. There h...
Data from MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Data from MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
<div>Abstract<p>Transcriptional regulator YAP is activated in multiple human cancers and plays critical roles in tumor initiation, progression, metastasis, and drug res...
Data from MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Data from MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
<div>Abstract<p>Transcriptional regulator YAP is activated in multiple human cancers and plays critical roles in tumor initiation, progression, metastasis, and drug res...
Abstract 2200: A rational approach for discovery of inhibitors of YAP-TEAD interaction
Abstract 2200: A rational approach for discovery of inhibitors of YAP-TEAD interaction
Abstract
The Hippo signalling pathway plays a major role in organ growth regulation and tumorigenesis. By sensing contact inhibition, the central kinase network of t...
227-OR: Disruption of Adipocyte YAP Improves Glucose Homeostasis in Mice and Decreases Adipose Tissue Fibrosis
227-OR: Disruption of Adipocyte YAP Improves Glucose Homeostasis in Mice and Decreases Adipose Tissue Fibrosis
Adipose tissue is a dynamic metabolic organ that is essential for the regulation of whole-body glucose homeostasis. Dysfunctional adipose tissue hypertrophy with obesity is associa...

